HAGAR is an Israeli diabetes monitoring platform that offers a non-invasive glucometer. HAGAR’s flagship product, GWave, is a sensor-enabled glucose monitoring system that uses radio frequency technology to measure glucose levels. Patients can access their glucose readings via the GWave smartphone app and share this data with their healthcare provider.
The company claims that its GWave sensors offer over 95% accuracy in blood glucose monitoring, surpassing standard handheld finger-prick devices, and measure glucose directly in the blood rather than in interstitial fluid, resulting in efficient and precise results.
As of May 2024, the company was yet to obtain FDA approval for its technology.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.